These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Genistein modulates prostate epithelial cell proliferation via estrogen- and extracellular signal-regulated kinase-dependent pathways. Wang X; Clubbs EA; Bomser JA J Nutr Biochem; 2006 Mar; 17(3):204-10. PubMed ID: 16198100 [TBL] [Abstract][Full Text] [Related]
4. Different mechanisms of soy isoflavones in cell cycle regulation and inhibition of invasion. Kim MH; Gutierrez AM; Goldfarb RH Anticancer Res; 2002; 22(6C):3811-7. PubMed ID: 12552999 [TBL] [Abstract][Full Text] [Related]
5. Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro. Hedlund TE; van Bokhoven A; Johannes WU; Nordeen SK; Ogden LG Prostate; 2006 Apr; 66(5):557-66. PubMed ID: 16372328 [TBL] [Abstract][Full Text] [Related]
6. Human cell lines as an in vitro/in vivo model for prostate carcinogenesis and progression. Webber MM; Quader ST; Kleinman HK; Bello-DeOcampo D; Storto PD; Bice G; DeMendonca-Calaca W; Williams DE Prostate; 2001 Apr; 47(1):1-13. PubMed ID: 11304724 [TBL] [Abstract][Full Text] [Related]
7. [Inhibition of genistein on the proliferation of RWPE-1 cells induced by testosterone under the control of insulin-like growth factor-1]. Ren G; Tang L; Zhu M; Yang L; Huang Y Wei Sheng Yan Jiu; 2010 Jul; 39(4):447-50. PubMed ID: 20726235 [TBL] [Abstract][Full Text] [Related]
8. Stem/progenitor and intermediate cell types and the origin of human prostate cancer. Tokar EJ; Ancrile BB; Cunha GR; Webber MM Differentiation; 2005 Dec; 73(9-10):463-73. PubMed ID: 16351690 [TBL] [Abstract][Full Text] [Related]
9. Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro. Hedlund TE; Johannes WU; Miller GJ Prostate; 2003 Jan; 54(1):68-78. PubMed ID: 12481257 [TBL] [Abstract][Full Text] [Related]
10. Soy isoflavones in the treatment of prostate cancer. Hussain M; Banerjee M; Sarkar FH; Djuric Z; Pollak MN; Doerge D; Fontana J; Chinni S; Davis J; Forman J; Wood DP; Kucuk O Nutr Cancer; 2003; 47(2):111-7. PubMed ID: 15087261 [TBL] [Abstract][Full Text] [Related]
11. Lycopene and soy isoflavones in the treatment of prostate cancer. Vaishampayan U; Hussain M; Banerjee M; Seren S; Sarkar FH; Fontana J; Forman JD; Cher ML; Powell I; Pontes JE; Kucuk O Nutr Cancer; 2007; 59(1):1-7. PubMed ID: 17927495 [TBL] [Abstract][Full Text] [Related]
12. Melatonin as a negative mitogenic hormonal regulator of human prostate epithelial cell growth: potential mechanisms and clinical significance. Tam CW; Chan KW; Liu VW; Pang B; Yao KM; Shiu SY J Pineal Res; 2008 Nov; 45(4):403-12. PubMed ID: 18637986 [TBL] [Abstract][Full Text] [Related]
13. Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line. Albrecht AL; Somji S; Sens MA; Sens DA; Garrett SH Biometals; 2008 Aug; 21(4):405-16. PubMed ID: 18097638 [TBL] [Abstract][Full Text] [Related]
14. Suppression of VEGF-mediated autocrine and paracrine interactions between prostate cancer cells and vascular endothelial cells by soy isoflavones. Guo Y; Wang S; Hoot DR; Clinton SK J Nutr Biochem; 2007 Jun; 18(6):408-17. PubMed ID: 17142033 [TBL] [Abstract][Full Text] [Related]
15. Soy isoflavone genistein modulates cell cycle progression and induces apoptosis in HER-2/neu oncogene expressing human breast epithelial cells. Katdare M; Osborne M; Telang NT Int J Oncol; 2002 Oct; 21(4):809-15. PubMed ID: 12239620 [TBL] [Abstract][Full Text] [Related]
16. Primary prostate cancer cultures are models for androgen-independent transit amplifying cells. Bühler P; Wolf P; Katzenwadel A; Schultze-Seemann W; Wetterauer U; Freudenberg N; Elsässer-Beile U Oncol Rep; 2010 Feb; 23(2):465-70. PubMed ID: 20043108 [TBL] [Abstract][Full Text] [Related]
17. The specific role of isoflavones in reducing prostate cancer risk. Kumar NB; Cantor A; Allen K; Riccardi D; Besterman-Dahan K; Seigne J; Helal M; Salup R; Pow-Sang J Prostate; 2004 May; 59(2):141-7. PubMed ID: 15042614 [TBL] [Abstract][Full Text] [Related]
18. Basal and metal-induced expression of metallothionein isoform 1 and 2 genes in the RWPE-1 human prostate epithelial cell line. Albrecht AL; Singh RK; Somji S; Sens MA; Sens DA; Garrett SH J Appl Toxicol; 2008 Apr; 28(3):283-93. PubMed ID: 17590860 [TBL] [Abstract][Full Text] [Related]
19. Inhibitory effects of O-methylated isoflavone glycitein on human breast cancer SKBR-3 cells. Zhang B; Su JP; Bai Y; Li J; Liu YH Int J Clin Exp Pathol; 2015; 8(7):7809-17. PubMed ID: 26339345 [TBL] [Abstract][Full Text] [Related]
20. Interferon-gamma induces neuroendocrine-like differentiation of human prostate basal-epithelial cells. Untergasser G; Plas E; Pfister G; Heinrich E; Berger P Prostate; 2005 Sep; 64(4):419-29. PubMed ID: 15800938 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]